Relationship Between Health-Related Quality of Life Measures and High HIV Viral Load in HIV-Infected Triple-Class-Experienced Patients

REFERENCES

• Fayers PM, Machin D. Quality of Life. The Assessment, Analysis and Interpretation of Patient-Reported Outcomes. New York: John Wiley & Sons; 2007.
   Google Scholar
• Nunnally JO. Psycometric Theory. New York: McGraw-Hill; 1978.
   Google Scholar
• Wu AW, Mathews WC, Brysk LT, et al. Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex. J Acquir Immune Defic Syndr. 1990;3(7):683–690.
   PubMed Web of Science ®Google Scholar
• De Boer JB. van Dam FS, Sprangers MA, Frissen PH, Lange JM. Longitudinal study on the quality of life of symptomatic HIV-infected patients in a trial of zidovu-dine versus zidovudine and interferon-alpha. AIDS. 1993;7(7):947–953.
   PubMed Web of Science ®Google Scholar
• Lenderking WR, Gelber RD, Cotton DJ, et al. Evaluation of the quality of life associated with zidovudine treat-ment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group. N Engl J Med. 1994;330(11):738–743.
   PubMed Web of Science ®Google Scholar
• Chatterton ML. Scott-Lennox J, Wu AW, Scott J. Qual-ity of life and treatment satisfaction after the addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens in treatment-experienced patients with HIV infection. Pharmacoeconomics. 1999;15(Suppl 1):67–74.
   PubMed Web of Science ®Google Scholar
• Revicki DA. Swartz C, Wu AW, Haubrich R, Collier AC. Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3. Antivir Ther. 1999;4(1):35–44.
   PubMed Web of Science ®Google Scholar
• Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents http://www.aidsinfo.nih.gov/. Accessed April 15,2007.
   Google Scholar
• Weinfurt KP, Willke RJ, Glick HA, Freimuth WW, Schulman KA. Relationship between CD4 count, viral burden, and quality of life over time in HIV-1-infected patients. Med Care. 2000;38(4):404–410.
   PubMed Web of Science ®Google Scholar
• Gill CJ, Griffith JL, Jacobson D, Skinner S, Gorbach SL, Wilson IB. Relationship of HIV viral loads, CD4 counts, and HAART use to health-related quality of life. J Acquir Immune Defic Syndr. 2002 ;30(5):485–492.
   PubMed Web of Science ®Google Scholar
• Call SA, Klapow JC, Stewart KE, et al. Health-related qual-ity of life and virologic outcomes in an HIV clinic. Qua/ Life Res. 2000;9(9):977–985.
   PubMed Web of Science ®Google Scholar
• Badia X, Podzamczer D, Garcia M, López-Lavid C, Con-siglio E. A randomized study comparing instruments for measuring health-related quality of life in HIV-infected patients. Spanish MOS-HIV and MQ0L-HIV Validation Group. Medical Outcomes Study HIV Health Survey. AIDS. 1999;13(13):1727–1735.
   PubMed Web of Science ®Google Scholar
• Murri R, Ammassari A, Fantoni M, et al. Disease-related factors associated with health-related quality of life in people with non advanced HIV disease assessed using an Italian version of the MOS-HIV Health Survey. J Acquir Immune Defic Syndr Human Retrovirol. 1997;16(5): 350–356.
   PubMedGoogle Scholar
• Burgoyne RW, Rourke SB, Behrens DM, Salit IE. Long-term quality-of-life outcomes among adults living with HIV in the HAART era: The interplay of changes in clinical fac-tors and symptom profile. AIDS Behav. 2004;8(2)151–163.
   Web of Science ®Google Scholar
• Jia H, Uphold CR, Wu S, Chen GJ, Duncan PW. Predictors of changes in health-related quality of life among men with HIV infection in the HAART era. AIDS Patient Care STDS. 2005;19(6):395–405.
   PubMed Web of Science ®Google Scholar
• Kemppainen JK. Predictors of quality of life in AIDS patients. J Assoc Nurses AIDS Care. 2001;12(1):61–70.
   PubMedGoogle Scholar
• Weimer L, Fragola V, Floridia M, et al. Response to ralte-gravir-based salvage therapy in HIV-infected patients with HCV or HBV coinfection. J Antimicrob Chemother. 2013;68(1)193–199.
   Web of Science ®Google Scholar
• Bucciardini R, D’Ettorre G, Baroncelli S, et al, for the ISS-NIA study group. Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors. Int J STD AIDS. 2012;23:459–463.
   PubMed Web of Science ®Google Scholar
• Bucciardini R, Murri R, Guarinieri M, et al. ISSQoL: A new questionnaire for evaluating the quality of life of people living with HIV in the HAART era. Qual Life Res. 2006;15:377–390.
   PubMed Web of Science ®Google Scholar
• Lauriola M, Murri R, Massella M, et al. A factor analytic study of the Italian National Institute of Health Quality of Life - Core Evaluation Form (ISSQoL-CEF). Preference Adherence. 2010;4: 33–44.
   PubMed Web of Science ®Google Scholar
• Cunningham WE, Crystal S, Bozzette SA, Hays RD. The association of health related quality of life with survival among persons with HIV Infection in the United States. J Gen Intern Med. 2005; 20(1):21–27.
   PubMed Web of Science ®Google Scholar
• Bastardo YM, Kimberlin CL. Relationship between qual-ity of life, social support and disease-related factors in HIV-infected persons in Venezuela. AIDS Care. 2000;12(5): 673–684.
   PubMed Web of Science ®Google Scholar
• Yadav S. Perceived social support, hope, and quality of life of persons living with HIV/AIDS: A case study from Nepal. Qua/ Life Res. 2010;19(2):157–166.
   PubMed Web of Science ®Google Scholar
• Jia H, Uphold CR, Wu S, Reid K, Findley K, Duncan PW. Health-related quality of life among men with HIV infection: Effects of social support, coping, and depression. AIDS Patient Care STDS. 2004;18(10):594–603.
   PubMed Web of Science ®Google Scholar
• Friedland J, Renwick R, McColl M. Coping and social sup-port as determinants of quality of life in HIV/AIDS. AIDS Care. 1996;8(1):15–31.
   PubMed Web of Science ®Google Scholar
• Justice AC, Rabeneck L, Hays RD, Wu AW, Bozzette SA, for the Outcomes Committee of the AIDS Clinical Trials Group. Sensitivity, specificity, reliability, and clinical valid-ity of provider-reported symptoms: A comparison with self-reported symptoms. J Acquir Immune Defic Syndr. 1999;21:126–133.
   PubMed Web of Science ®Google Scholar
• Cunningham WE, Shapiro MF, Hays RD, et al. Con-stitutional symptoms and health-related quality of life in patients with symptomatic HIV disease. Am J Med. 1998;104:129–136.
   PubMed Web of Science ®Google Scholar
• Lorenz KA, Cunningham WE, Spritzer KL, et al. Changes in symptoms and health related quality of life in a nationally representative sample of adults in treatment for HIV. Qua/ Life Res. 2006;15:951–958
   PubMed Web of Science ®Google Scholar
• Lorenz KA, Shapiro MF, Asch SM, Bozzette SA, Hays RD. Associations of symptoms and health-related quality of life: Findings from a national study of persons with HIV infection. Ann Intern Med. 2001;134(9 Pt 2): 854–860.
   PubMed Web of Science ®Google Scholar
• Franchi D, Wenzel RP. Measuring health-related quality of life among patients infected with human immunodefi-ciency virus. Clin Infect Dis. 1998;26:20–26.
   PubMed Web of Science ®Google Scholar
• Haynes RB, Taylor DW, Sackett DL. Compliance in Health Care. Baltimore, MD: Johns Hopkins University Press; 1979.
   Google Scholar
• Barnhoorn F, Adriaanse H. In search of factors responsible for noncompliance among tuberculosis patients in Wardha District, India. Soc Sc/Med. 1992;34:291–306.
   PubMed Web of Science ®Google Scholar
• Ammassari A, Murri R, Pezzotti P, et al, for the AdICONA Study Group. Self-reported symptoms and medication side effects influence adherence to highly active anti-retroviral therapy in patients with HIV infection. J Acquir Immune Deficy Syndr. 2001;28:445–449.
   PubMed Web of Science ®Google Scholar
• Webb A, Norton M. Clinical assessment of symptom-focused health-related quality of life in HIV/AIDS. J Assoc Nurses AIDS Care. 2004;15(2):678–681.
   Web of Science ®Google Scholar
• Grossman HA, Sullivan PS, Wu AW. Quality of life and HIV: Current assessment tools and future directions for clinical practice. AIDS Reader. 2003;13(12):583–590, 595–597.
   PubMedGoogle Scholar